Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Cantor Fitzgerald
Covington
Mallinckrodt
Accenture
Express Scripts
US Department of Justice
AstraZeneca
Farmers Insurance
Federal Trade Commission

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016093

« Back to Dashboard

NDA 016093 describes EDECRIN, which is a drug marketed by Aton and is included in two NDAs. It is available from four suppliers. Additional details are available on the EDECRIN profile page.

The generic ingredient in EDECRIN is ethacrynic acid. There are twelve drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the ethacrynic acid profile page.
Summary for 016093
Tradename:EDECRIN
Applicant:Aton
Ingredient:ethacrynate sodium
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 016093
Suppliers and Packaging for NDA: 016093
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EDECRIN ethacrynate sodium INJECTABLE;INJECTION 016093 NDA Aton Pharma, Inc. 25010-210 N 25010-210-27
EDECRIN ethacrynate sodium INJECTABLE;INJECTION 016093 NDA AUTHORIZED GENERIC Oceanside Pharmaceuticals 68682-012 N 68682-012-50

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 50MG BASE/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Covington
Merck
Julphar
Daiichi Sankyo
Accenture
Queensland Health
Dow
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot